Patent · US Expired

Quinolines and their therapeutic use

US6069151A · kind A · utility

42Cited by
5References
21Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJun 17, 1998
Grant dateMay 30, 2000
Priority date
Expiry dateJun 17, 2018

Classification

  • Technology area (CPC Y)Emerging Cross-Sectional Technologies
  • CPC primaryY02A50/30
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Compounds of the formula ##STR1## have therapeutic utility, as inhibitors of phosphodiesterase IV and TNF release.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.